Advertisement
CRDL vs EOLS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRDL is a Hold and EOLS is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CRDL’s FA Score shows that 0 FA rating(s) are green whileEOLS’s FA Score has 0 green FA rating(s).
- CRDL’s FA Score: 0 green, 5 red.
- EOLS’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CRDL’s TA Score shows that 5 TA indicator(s) are bullish while EOLS’s TA Score has 4 bullish TA indicator(s).
- CRDL’s TA Score: 5 bullish, 5 bearish.
- EOLS’s TA Score: 4 bullish, 5 bearish.
Price Growth
CRDL (@Pharmaceuticals: Other) experienced а -27.18% price change this week, while EOLS (@Pharmaceuticals: Other) price change was -31.95% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.12%. For the same industry, the average monthly price growth was +73.14%, and the average quarterly price growth was +82.67%.
Reported Earning Dates
CRDL is expected to report earnings on Aug 18, 2025.
EOLS is expected to report earnings on Nov 11, 2025.
Industries' Descriptions
@Pharmaceuticals: Other (+3.12% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| CRDL | EOLS | CRDL / EOLS | |
| Capitalization | 124M | 847M | 15% |
| EBITDA | -30.61M | -41.81M | 73% |
| Gain YTD | -15.234 | -45.018 | 34% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 0 | 202M | - |
| Total Cash | 40.5M | 62.8M | 64% |
| Total Debt | 181K | 127M | 0% |
CRDL | EOLS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 7 | 51 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 96 Overvalued | 90 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 77 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 90 | 95 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 85 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
EOLS's Valuation (90) in the Pharmaceuticals Major industry is in the same range as CRDL (96) in the null industry. This means that EOLS’s stock grew similarly to CRDL’s over the last 12 months.
EOLS's Profit vs Risk Rating (77) in the Pharmaceuticals Major industry is in the same range as CRDL (100) in the null industry. This means that EOLS’s stock grew similarly to CRDL’s over the last 12 months.
EOLS's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as CRDL (100) in the null industry. This means that EOLS’s stock grew similarly to CRDL’s over the last 12 months.
CRDL's Price Growth Rating (90) in the null industry is in the same range as EOLS (95) in the Pharmaceuticals Major industry. This means that CRDL’s stock grew similarly to EOLS’s over the last 12 months.
CRDL's P/E Growth Rating (100) in the null industry is in the same range as EOLS (100) in the Pharmaceuticals Major industry. This means that CRDL’s stock grew similarly to EOLS’s over the last 12 months.
| CRDL | EOLS | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 86% |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 75% |
| Momentum ODDS (%) | 1 day ago 88% | 1 day ago 86% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 80% |
| TrendWeek ODDS (%) | 1 day ago 87% | 1 day ago 83% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 82% |
| Advances ODDS (%) | 8 days ago 85% | 15 days ago 80% |
| Declines ODDS (%) | 4 days ago 87% | 1 day ago 81% |
| BollingerBands ODDS (%) | 1 day ago 86% | 1 day ago 82% |
| Aroon ODDS (%) | 1 day ago 88% | 1 day ago 76% |
Advertisement
CRDL and
Correlation & Price change
A.I.dvisor tells us that CRDL and TLRY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRDL and TLRY's prices will move in lockstep.
| Ticker / NAME | Correlation To CRDL | 1D Price Change % | ||
|---|---|---|---|---|
| CRDL | 100% | +1.40% | ||
| TLRY - CRDL | 32% Poorly correlated | +5.40% | ||
| LNTH - CRDL | 32% Poorly correlated | +5.76% | ||
| SCYX - CRDL | 30% Poorly correlated | +23.41% | ||
| ACB - CRDL | 30% Poorly correlated | -0.59% | ||
| EOLS - CRDL | 29% Poorly correlated | -4.71% | ||
More | ||||
EOLS and
Correlation & Price change
A.I.dvisor indicates that over the last year, EOLS has been loosely correlated with PRGO. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if EOLS jumps, then PRGO could also see price increases.
| Ticker / NAME | Correlation To EOLS | 1D Price Change % | ||
|---|---|---|---|---|
| EOLS | 100% | -4.71% | ||
| PRGO - EOLS | 40% Loosely correlated | -3.30% | ||
| AMRX - EOLS | 35% Loosely correlated | +1.99% | ||
| TAK - EOLS | 28% Poorly correlated | +0.63% | ||
| AQST - EOLS | 28% Poorly correlated | -1.50% | ||
| ALKS - EOLS | 27% Poorly correlated | +0.19% | ||
More | ||||